Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis.
A 22-year-old male with extensive steroid-dependent/azathioprine-refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti-TNFα in steroid-dependent IBD patients needing therapy with this class of drugs.
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Antonio
A
Rispo
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Dario
D
Musto
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Nicola
N
Imperatore
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Anna
A
Testa
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Matilde
M
Rea
Gastroenterology - Department of Clinical Medicine and Surgery - School of Medicine "Federico II" of Naples Via S. Pansini 5 Naples 80131 Italy.
Fabiana
F
Castiglione
Acne pustolosa; adalimumab; inflammatory bowel diseases; infliximab; tumor necrosis factor alpha; ulcerative colitis